Suppr超能文献

天然产物冬凌草甲素启发的抗癌药物的发现与开发。

Discovery and development of natural product oridonin-inspired anticancer agents.

作者信息

Ding Ye, Ding Chunyong, Ye Na, Liu Zhiqing, Wold Eric A, Chen Haiying, Wild Christopher, Shen Qiang, Zhou Jia

机构信息

Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, 77555, United States.

Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States.

出版信息

Eur J Med Chem. 2016 Oct 21;122:102-117. doi: 10.1016/j.ejmech.2016.06.015. Epub 2016 Jun 13.

Abstract

Natural products have historically been, and continue to be, an invaluable source for the discovery of various therapeutic agents. Oridonin, a natural diterpenoid widely applied in traditional Chinese medicines, exhibits a broad range of biological effects including anticancer and anti-inflammatory activities. To further improve its potency, aqueous solubility and bioavailability, the oridonin template serves as an exciting platform for drug discovery to yield better candidates with unique targets and enhanced drug properties. A number of oridonin derivatives (e.g. HAO472) have been designed and synthesized, and have contributed to substantial progress in the identification of new agents and relevant molecular mechanistic studies toward the treatment of human cancers and other diseases. This review summarizes the recent advances in medicinal chemistry on the explorations of novel oridonin analogues as potential anticancer therapeutics, and provides a detailed discussion of future directions for the development and progression of this class of molecules into the clinic.

摘要

从历史上看,天然产物一直是并将继续是发现各种治疗药物的宝贵来源。冬凌草甲素是一种广泛应用于传统中药的天然二萜类化合物,具有广泛的生物学效应,包括抗癌和抗炎活性。为了进一步提高其效力、水溶性和生物利用度,冬凌草甲素模板成为药物发现的一个令人兴奋的平台,以产生具有独特靶点和增强药物特性的更好候选药物。已经设计并合成了许多冬凌草甲素衍生物(如HAO472),并在鉴定新药物以及针对人类癌症和其他疾病治疗的相关分子机制研究方面取得了重大进展。本综述总结了药物化学领域在探索新型冬凌草甲素类似物作为潜在抗癌治疗药物方面的最新进展,并详细讨论了这类分子开发和推进至临床应用的未来方向。

相似文献

1
Discovery and development of natural product oridonin-inspired anticancer agents.
Eur J Med Chem. 2016 Oct 21;122:102-117. doi: 10.1016/j.ejmech.2016.06.015. Epub 2016 Jun 13.
3
Recent Development of Oridonin Derivatives with Diverse Pharmacological Activities.
Mini Rev Med Chem. 2019;19(2):114-124. doi: 10.2174/1389557517666170417170609.
4
Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
Anticancer Agents Med Chem. 2019;19(7):935-947. doi: 10.2174/1871520619666190118121439.
5
Chemical proteomics reveals HSP70 1A as a target for the anticancer diterpene oridonin in Jurkat cells.
J Proteomics. 2013 Apr 26;82:14-26. doi: 10.1016/j.jprot.2013.01.030. Epub 2013 Feb 15.
7
Recent Progress of Oridonin and Its Derivatives for the Treatment of Acute Myelogenous Leukemia.
Mini Rev Med Chem. 2020;20(6):483-497. doi: 10.2174/1389557519666191029121809.
10
The Natural Product Oridonin as an Anticancer Agent: Current Achievements and Problems.
Curr Pharm Biotechnol. 2024;25(6):655-664. doi: 10.2174/1389201024666230821110116.

引用本文的文献

1
Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications.
Cell Death Discov. 2025 Aug 25;11(1):405. doi: 10.1038/s41420-025-02696-2.
2
Integrated miRNAome, transcriptome, and degradome analyses reveal the role of miRNA-mRNA modules in the biosynthesis of oridonin in .
Front Plant Sci. 2025 Jun 18;16:1566354. doi: 10.3389/fpls.2025.1566354. eCollection 2025.
3
Research progress and molecular mechanism of oridonin in the treatment of malignant melanoma.
Front Oncol. 2025 Jun 17;15:1606325. doi: 10.3389/fonc.2025.1606325. eCollection 2025.
4
Diterpenoids from the aerial parts of and their anti-hepatocarcinoma potential.
RSC Adv. 2025 Jun 23;15(25):20134-20142. doi: 10.1039/d5ra02720a. eCollection 2025 Jun 10.
5
Isodon rubescens research literature based on Web of Science database for visual analysis: A review.
Medicine (Baltimore). 2025 May 2;104(18):e41945. doi: 10.1097/MD.0000000000041945.
7
Enhancing cancer therapy: advanced nanovehicle delivery systems for oridonin.
Front Pharmacol. 2024 Dec 3;15:1476739. doi: 10.3389/fphar.2024.1476739. eCollection 2024.
10
An iron-based metal-organic framework nanoplatform for enhanced ferroptosis and oridonin delivery as a comprehensive antitumor strategy.
Acta Pharm Sin B. 2024 Sep;14(9):4073-4086. doi: 10.1016/j.apsb.2024.05.015. Epub 2024 May 24.

本文引用的文献

2
A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5.
Cancer Lett. 2016 Oct 1;380(2):393-402. doi: 10.1016/j.canlet.2016.06.024. Epub 2016 Jul 4.
3
Probing the Anticancer Action of Oridonin with Fluorescent Analogues: Visualizing Subcellular Localization to Mitochondria.
J Med Chem. 2016 May 26;59(10):5022-34. doi: 10.1021/acs.jmedchem.6b00408. Epub 2016 Apr 27.
4
Natural Products as Sources of New Drugs from 1981 to 2014.
J Nat Prod. 2016 Mar 25;79(3):629-61. doi: 10.1021/acs.jnatprod.5b01055. Epub 2016 Feb 7.
6
BH4 domain of Bcl-2 as a novel target for cancer therapy.
Drug Discov Today. 2016 Jun;21(6):989-96. doi: 10.1016/j.drudis.2015.11.008. Epub 2015 Nov 26.
7
Anti-parasite drugs sweep Nobel prize in medicine 2015.
Nature. 2015 Oct 8;526(7572):174-5. doi: 10.1038/nature.2015.18507.
8
Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.
J Surg Res. 2015 Dec;199(2):441-9. doi: 10.1016/j.jss.2015.07.042. Epub 2015 Aug 5.
9
Direct Activation of Bax Protein for Cancer Therapy.
Med Res Rev. 2016 Mar;36(2):313-41. doi: 10.1002/med.21379. Epub 2015 Sep 23.
10
Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells.
Mol Cell Biochem. 2015 Dec;410(1-2):293-300. doi: 10.1007/s11010-015-2562-4. Epub 2015 Sep 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验